JP2020510680A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510680A5
JP2020510680A5 JP2019548683A JP2019548683A JP2020510680A5 JP 2020510680 A5 JP2020510680 A5 JP 2020510680A5 JP 2019548683 A JP2019548683 A JP 2019548683A JP 2019548683 A JP2019548683 A JP 2019548683A JP 2020510680 A5 JP2020510680 A5 JP 2020510680A5
Authority
JP
Japan
Prior art keywords
dialysate
spiked
thiosulfate
pharmaceutical composition
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019548683A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020510680A (ja
JP7416622B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/021069 external-priority patent/WO2018165108A1/en
Publication of JP2020510680A publication Critical patent/JP2020510680A/ja
Publication of JP2020510680A5 publication Critical patent/JP2020510680A5/ja
Priority to JP2024000105A priority Critical patent/JP7642878B2/ja
Application granted granted Critical
Publication of JP7416622B2 publication Critical patent/JP7416622B2/ja
Priority to JP2025028476A priority patent/JP2025084833A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019548683A 2017-03-08 2018-03-06 チオ硫酸ナトリウムの透析中の使用 Active JP7416622B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024000105A JP7642878B2 (ja) 2017-03-08 2024-01-04 チオ硫酸ナトリウムの透析中の使用
JP2025028476A JP2025084833A (ja) 2017-03-08 2025-02-26 チオ硫酸ナトリウムの透析中の使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762468871P 2017-03-08 2017-03-08
US62/468,871 2017-03-08
PCT/US2018/021069 WO2018165108A1 (en) 2017-03-08 2018-03-06 Intradialytic use of sodium thiosulfate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024000105A Division JP7642878B2 (ja) 2017-03-08 2024-01-04 チオ硫酸ナトリウムの透析中の使用

Publications (3)

Publication Number Publication Date
JP2020510680A JP2020510680A (ja) 2020-04-09
JP2020510680A5 true JP2020510680A5 (https=) 2021-04-22
JP7416622B2 JP7416622B2 (ja) 2024-01-17

Family

ID=63446695

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019548683A Active JP7416622B2 (ja) 2017-03-08 2018-03-06 チオ硫酸ナトリウムの透析中の使用
JP2024000105A Active JP7642878B2 (ja) 2017-03-08 2024-01-04 チオ硫酸ナトリウムの透析中の使用
JP2025028476A Pending JP2025084833A (ja) 2017-03-08 2025-02-26 チオ硫酸ナトリウムの透析中の使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024000105A Active JP7642878B2 (ja) 2017-03-08 2024-01-04 チオ硫酸ナトリウムの透析中の使用
JP2025028476A Pending JP2025084833A (ja) 2017-03-08 2025-02-26 チオ硫酸ナトリウムの透析中の使用

Country Status (14)

Country Link
US (5) US10744156B2 (https=)
EP (2) EP4403215A3 (https=)
JP (3) JP7416622B2 (https=)
KR (4) KR20250007674A (https=)
AR (1) AR111236A1 (https=)
AU (1) AU2018231072B2 (https=)
CA (1) CA3055107A1 (https=)
ES (1) ES2992792T3 (https=)
IL (4) IL268883B (https=)
NZ (4) NZ788158A (https=)
PH (1) PH12019501971A1 (https=)
TW (2) TWI869743B (https=)
WO (1) WO2018165108A1 (https=)
ZA (2) ZA202105781B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL268883B (en) 2017-03-08 2022-09-01 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
CN112805238A (zh) 2018-07-03 2021-05-14 芬内克制药股份有限公司 无水硫代硫酸钠和其调配物
US11850313B2 (en) * 2019-12-20 2023-12-26 The London Health Sciences Centre Research Inc. Method and compositions for protecting tissue
WO2024092228A2 (en) * 2022-10-28 2024-05-02 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Localized delivery of sodium thiosulfate nanoparticles to mitigate arterial calcification
CN116573782B (zh) * 2023-04-03 2023-11-03 迁安市宏奥工贸有限公司 脱硫废液的处理方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218900B1 (en) 1985-09-10 1992-01-22 Research Corporation Technologies, Inc. Osmotic agents for peritoneal dialysis
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
US6380163B1 (en) 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
FI98538C (fi) * 1993-10-20 1997-07-10 Enso Gutzeit Oy Menetelmä natriumhydroksidin valmistamiseksi valkolipeästä
US6306836B1 (en) 1994-01-21 2001-10-23 Baxter International Inc. Peritoneal dialysis solutions containing maltodextrins and amino acids
US6436969B1 (en) 1995-09-12 2002-08-20 Kansas University Medical Center Research Institute Inc. Dialysis solutions and methods
ES2322689T3 (es) * 1999-09-22 2009-06-25 Advanced Renal Technologies Uso de un dializado con elevado contenido de citrato.
US7022315B2 (en) * 2000-04-26 2006-04-04 Oregon Health & Science University Administration of a thiol-based chemoprotectant compound
JP4882054B2 (ja) * 2000-09-13 2012-02-22 独立行政法人科学技術振興機構 腹膜透析液およびその調製法
JP5564158B2 (ja) 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 亜硝酸塩によって特定の心臓血管状態を処置する方法
WO2006001345A1 (ja) 2004-06-23 2006-01-05 Kyowa Hakko Kogyo Co., Ltd. Ｌ－リジン・クエン酸塩結晶
US20070154570A1 (en) 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
US7834065B2 (en) 2005-01-31 2010-11-16 Bmg Incorporated Medical-use two part reactive adhesive and medical-use resin having self-degradation property
US20090304600A1 (en) 2008-06-09 2009-12-10 Anupkumar Shetty Intradialytic administration of sodium thiosulfate
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
AU2010270605B2 (en) 2009-07-08 2014-07-31 Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals Sodium thiosulfate-containing pharmaceutical compositions
CA2844759A1 (en) 2011-08-11 2013-02-14 Nathan S. Bryan Method of measuring and monitoring in vivo nitrite levels
WO2013112582A1 (en) 2012-01-23 2013-08-01 Santalis Pharmaceuticals Inc. Sandalwood oil and its uses related to clostridium infections
US9629872B2 (en) * 2012-05-10 2017-04-25 Inserm (Institut National De La Sante Et De La Recherche Medicale) Sodium thiosulphate for the treatment of ectopic calcifications
JP5486069B1 (ja) * 2012-11-05 2014-05-07 旭 酒井 透析装置
US20140350097A1 (en) 2013-05-23 2014-11-27 Medinox,Inc. Treatment of hypotension associated with hemodialysis
WO2016094409A1 (en) * 2014-12-09 2016-06-16 Villarreal Anna Methods and devices for female health monitoring
IL268883B (en) * 2017-03-08 2022-09-01 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
BR112019018861A2 (pt) 2017-03-08 2023-10-10 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Uso de nitrito de sódio, método para manter os níveis fisiológicos de nitrito, prevenir enfarte do miocárdio, prevenir morte súbita cardíaca, prevenir acidente vascular cerebral, doenças cardiovasculares, pressão alta, solução aquosa

Similar Documents

Publication Publication Date Title
JP2020510680A5 (https=)
JP2020510014A5 (https=)
Warden Burn shock resuscitation
CN102985071B (zh) 透析前体组合物
Langston et al. Applications and outcome of hemodialysis in cats: a review of 29 cases
US6610206B1 (en) Buffered compositions for dialysis
Soussi et al. Chloride toxicity in critically ill patients: What's the evidence?
JP2017002035A5 (https=)
Borkan Extracorporeal therapies for acute intoxications
Hayes et al. Intradialytic hypotension
Ortega et al. Contrast-induced nephropathy: pathogenesis and new therapeutic options for prevention
Simpson et al. Ultrafiltration in diuretic-resistant cardiac failure
Skull Circulation-anatomy, physiology and pathophysiology
Borghi et al. Omega-3 fatty acids: A promising possible treatment for Meniere’s Disease and other inner ear disorders of unknown origin?
ES2862649T3 (es) Fluido de diálisis sin calcio
US20050142212A1 (en) Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
Alwan et al. Intradialytic hypotension complication, in cardiac and non cardiac risky end stage renal disease (ESRD) patients
BARRETO 47 Drug Dosing in Kidney Dysfunction
Leunissen et al. Acute dialysis complications
Bercovitch et al. Hyperkalemia provoked by acute hepatic necrosis
CN105246502A (zh) 用于防止或减少脑和全身再灌注损伤的保护液
Maurya et al. Comparative analysis between two crystalloid balanced electrolyte priming solution (Plasma-Lyte®-a and Sterofundin Iso) in adult patient undergoing cardiopulmonary bypass in the cardiac surgery
Foringer et al. Potassium disorders
Thornhill et al. Current Status Of Hemodialysis In Veterinary Medicine And The Development Of The Canine Animal Model For Hemodialysis-Related Disorders In Man
FR2613228A1 (fr) Composition rehydratante a base de glucose utile notamment dans le traitement des etats diarrheiques et des etats de chocs chez le veau